Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus

AIM: The efficacy and safety of insulin aspart (IAsp), a rapid-acting human insulin analogue, were compared with regular human insulin (HI) as the bolus component of basal-bolus therapy for subjects with gestational diabetes mellitus (GDM). METHODS: In a randomized, parallel-group, open-labelled tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Pettitt, D. J., Ospina, P., Howard, C., Zisser, H., Jovanovic, L.
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2121124/
https://www.ncbi.nlm.nih.gov/pubmed/17888133
http://dx.doi.org/10.1111/j.1464-5491.2007.02247.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2121124/
https://www.ncbi.nlm.nih.gov/pubmed/17888133
http://dx.doi.org/10.1111/j.1464-5491.2007.02247.x

Ejemplares similares